Prolife Industries Approves Half-Yearly Financial Results and Appoints Internal Auditor

Prolife Industries Approves Half-Yearly Financial Results and Appoints Internal Auditor

Prolife Industries Approves Half-Yearly Financial Results and Appoints Internal Auditor​

Prolife Industries Limited announced the approval of its Standalone Audited Financial Results for the half year and year ended March 31, 2026. The company also confirmed the appointment of M/s Paresh V. Soni & Co., Chartered Accountants, as the Internal Auditor for the Financial Year 2026-27.

The company's Board of Directors held its meeting on May 29, 2026, during which the audited financial results for the half year and year ended March 31, 2026, were considered and approved.

Financial Performance Highlights​

The company submitted detailed financial results spanning various periods, including the current half year and year-to-date figures.

The consolidated revenue figures show the following comparisons for the half year ended March 31, 2026, and the year to date period:

ParticularsPreceding 6 months ended 31/03/2026Preceding 6 months ended 30/09/2025Preceding 6 months ended 31/03/2025Preceding 6 months ended 30/09/2024Year to date figures for current period ended 31/03/2026Year to date figures for current period ended 31/03/2025
Total Revenue2,805.922,930.243,042.132,712.815,736.165,754.94
Total Expenses2,421.002,728.882,890.762,232.365,149.895,123.12
Profit / (loss) before exceptional and extraordinary items384.92201.36151.38480.45586.28631.82
Profit / (loss) after tax276.21149.1892.39375.45425.39467.84
Earnings Per Share (Basic)6.753.642.269.1710.3911.43

Balance Sheet and Cash Flow Summary​

The Balance Sheet and Cash Flow Statements for the period ended March 31, 2026, compared to the previous year, are detailed as follows:

Standalone Statement of Assets and Liabilities (Rs. in lakhs)

ParticularsAs at 31/03/2026 (Audited)As at 31/03/2025 (Audited)
EQUITY AND LIABILITIES
Share capital409.41409.41
Reserves and surplus4,550.934,137.82
Sub-total - Shareholders' funds4,960.344,547.23
Long-term borrowings27.34258.34
Other long-term liabilities27.0027.00
Sub-total - Non-current liabilities105.89316.94
Total outstanding of micro enterprises and small dues enterprises129.47222.01
Sub-total - Current liabilities372.88169.68
TOTAL - EQUITY AND LIABILITIES5,439.105,332.53
ASSETS
Sub-total - Non-current assets1,814.522,058.09
Sub-total - Current assets3,274.4411.95
TOTAL - ASSETS3,624.583,274.44

Cash Flow from Operating Activities (Rs. in lakhs)

PARTICULARSYear Ended March 31, 2026Year Ended March 31, 2025
Net Profit (Loss) As per Profit & Loss Account425.39467.84
Net Profit (Loss) before tax586.28631.82
Net Cash Flow from Operating Activities(163.92)(124.72)

Cash Flow from Investing Activities (Rs. in lakhs)

PARTICULARSYear Ended March 31, 2026Year Ended March 31, 2025
Net Cash Flow from Investing Activities265.74(118.20)

Cash Flow from Financing Activities (Rs. in lakhs)

PARTICULARSYear Ended March 31, 2026Year Ended March 31, 2025
Net Cash Flow from Financing Activities(232.34)(169.46)
Net Increase in Cash and Equivalent.(130.52)(412.38)

Audit and Governance Updates​

The standalone financial results were audited by M/s Bihari Shah & Co., Chartered Accountants. The audit reported an unmodified opinion on the financial results for the half year and year ended March 31, 2026.

Furthermore, the Board of Directors approved the appointment of M/s Paresh V. Soni & Co., Chartered Accountants, as the Internal Auditor of the Company for the Financial Year 2026-27.

PROLIFE Stock Price Movement​

Shares of Prolife Industries Limited today slipped by 5.00% to settle at ₹57. The stock finished the session with a volume of 500 shares traded, marking a significant drop from previous levels.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top